MLLT1 and leukemia: While cells expressing a control sgRNA showed robust contribution to MLL-ENL-induced leukemia in vivo (56%), cells carrying Setd2-mutations induced by two different sgRNAs were clearly underrepresented in the leukemic population (5–25%, Fig. 7e, f).